Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2025-03-06 00:00:00 ET · period of report 2025-03-05 · accession 0001415889-25-007299 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-06 | 2025-03-05 | ACAD | GAROFALO ELIZABETH A. | Dir | S - Sale | $18.23 | -4,919 | 17.6K | -22% | -$89.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | S | D | 4,919 | $18.23 | 17,595 | D | — | — |